Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

stocks to watch

Article Index

Stocks to Watch This Week: Goldman Sachs Group (GS), Netflix (NFLX), General Electric (NYSE: GE)

Goldman Sachs stock

There are a number of economic reports coming out this week, including the Beige Book and the jobless report.

Plus, a number of companies will report Q4 and 2016 full-year earnings. And the presidential inauguration is Friday.

With a busy economic week ahead, here are the top stocks to watch this week...

Stocks to Watch Today: Bank of America Corp. (BAC), JPMorgan Chase & Co. (JPM), Wells Fargo Co. (WFC)

stocks to watch today

Banks make our stocks to watch today (Friday) list with Bank of America Corp. (NYSE: BAC), JPMorgan Chase & Co. (NYSE: JPM), and Wells Fargo Co. (NYSE: WFC) out with earnings reports.

BAC and JPM beat, while WFC missed.

Here are the details and what lies ahead for three of America's biggest banks...

Stocks to Watch Thursday: Apple Inc. (AAPL), Delta Air Lines Inc. (DAL), Twitter Inc. (TWTR)

stocks to watch

Earning spots on our stocks to watch today (Thursday) list are Apple Inc. (Nasdaq: AAPL), Delta Air Lines Inc. (NYSE: DAL), and Twitter Inc. (NYSE: TWTR).

Driving the trio are earnings, analyst opinions, and reports of a new venture.

Here's what to watch in today's market...

Stocks to Watch Today: Biocept Inc. (BIOC), Sarepta Therapeutics Inc. (SRPT), Brookdale Senior Living Inc. (BKD)

stocks to watch

The three top stocks to watch today are Biocept Inc. (Nasdaq: BIOC), Sarepta Therapeutics Inc. (Nasdaq: SRPT), and Brookdale Senior Living Inc. (Nasdaq: BKD).

The trio are moving on M&A chatter, drug sales data, and network agreement news.

Here are the details...

Stocks to Watch Today: Chipotle Mexican Grill (CMG), Barracuda Networks (CUDA), Valeant Pharmaceuticals (VRX)

stocks to watch

Landing on today's (Tuesday) stocks to watch list are Chipotle Mexican Grill (NYSE: CMG), Barracuda Networks Inc. (Nasdaq: CUDA), and Valeant Pharmaceuticals International Inc. (NYSE: VRX).

The trio is moving on earnings, guidance, and M&A activity.

Here are the details...

Stocks to Watch Today: Global Payments (GPN), Lululemon Athletica (LULU), and Ariad Pharmaceuticals (ARIA)

Lululemon Athletica Inc. (LULU) Stock

Markets opened mixed Monday with Dow 20,000 still in reach.

Geopolitical risks weighed on markets, and market participants are prepping for some key earnings this week.

Three stocks to watch today include Global Payments (NYSE: GPN), Lululemon (Nasdaq: LULU), and Ariad Pharmaceuticals (Nasdaq: ARIA)...

Top Stocks to Watch Today: Gap Inc. (GPS), Amgen Inc. (AMGN), Toyota Motor Corp. (TM)

Top stocks to watch today

A retailer, a biotech, and an automaker make our top stocks to watch today (Friday) list.

Moving in early trading are Gap Inc. (NYSE: GPS), Amgen Inc. (Nasdaq: AMGN), and Toyota Motor Corp. (NYSE ADR: TM).

Here what is moving shares of these stocks to watch today...

5 Top CES Companies to Watch Now

CES companies

The 2017 CES show is billed as the largest, most diverse event experience ever in the show's 50-year history.

Established tech companies and startups are showcasing their latest products.

With that in mind, we're featuring the five top CES companies and stocks to watch now...

Stocks to Watch Today: Macy's Inc. (M), Inc. (AMZN), Kohl's Corp. (KSS)

Stocks to Watch

U.S. markets were under pressure today (Thursday), dragged lower by retailers including Macy's Inc. (NYSE: M) and Kohl's (NYSE: KSS). Inc. (Nasdaq: AMZN) was rising, on the other hand.

Here's why these are the three top stocks to watch today...

Stocks to Watch Today: Bed Bath & Beyond Inc. (BBBY), Micron Technology Inc. (MU), Rite Aid Corp. (RAD)

stocks to watch

A flurry of economic data is due today (Thursday), yet earnings are the key driver of today's stocks to watch.

Today's three top stocks to watch include Bed Bath & Beyond Inc. (Nasdaq: BBBY), Micron Technology Inc. (Nasdaq: MU), and Rite Aid Corp. (NYSE: RAD).

Here's what's moving the trio of stocks to watch today...

This Shipping Company's Stock Is Rising – No Matter What Amazon Does

shipping company

In its quest to become more than just the king of e-commerce, Amazon has set its sights on global shipping and logistics.

Individual investors and Wall Street alike feel this is a poor time to invest in the other major shipping firms.

But that's a misguided notion. In fact, this global shipping company is so competitive and innovative that it'll flourish no matter what Amazon does...

Profit from 2016 IPOs with These Two "Icebreakers"

2016 IPOS

Yes, there's been a low volume of 2016 IPOs due to broader market volatility.

But the IPO market is about to stage a massive turnaround.

And this chart examines why the 2016 IPO market is ready to bounce back...

How to Protect Your Biotech Profits from This Legal Limbo

biotech profits

Gilead Sciences Inc.'s Sovaldi was a real breakthrough in the fight against the chronic liver disease hepatitis C (HCV). The condition may show no symptoms for years after initial infection but can slowly become debilitating.

Hepatitis C affects as many as 200 million people worldwide, and before Sovaldi, the approved drug regimen could treat only about 50% of cases and could cause serious side effects. Treatment was generally long - 24 to 48 weeks - and arduous.

Sovaldi, on the other hand, could cure more than 90% of cases in a matter of weeks at a cost, in the United States, of around $94,000. The pricing caused controversy, but the drug proved transformative for HCV patients, their families, and doctors.

Sovaldi also proved a huge windfall for investors when it received FDA approval in 2013 and entered the pharmaceutical marketplace the following year.

So far, Gilead shareholders have seen a 2:1 split, several dividend payouts, and gains of more than 155% since 2013. Sales of Sovaldi and Gilead's other HCV drug, Harvoni, topped $12.5 billion in 2015 alone.

There's just one big, expensive problem...

The "BANG Stocks" Are the Next Group of Profit-Doublers


The market-leading FANG stocks - Facebook,, Netflix, and the former Google, now Alphabet - haven't had a great 2016, with returns in the neighborhood of -15% to just under 5% for the year.

Don't get me wrong - they're still good "holds" for investors wise enough to take the long view and accumulate big, steady gains over a period of years.

Those anemic gains aren't surprising, given that we're all but "officially" in the depths of a bear market.

But... like the old adage goes, "there's always a bull market somewhere," and I believe that's especially true of the basket of stocks I'm about to show you. As uncertainty and volatility rule the markets, these shares have already delivered bona fide breakout gains that most investors would kill for right now.

But you haven't missed out; there's a new technology just hitting its stride right now that could multiply these players' profits exponentially.

And the best part is they're all still available at real bargain prices.

They won't stay that way, though...

Here’s How Investors Get Tricked into Buying Companies Like Valeant


While half the trick of investing is figuring out what the consensus thinks, the wisdom of crowds is a myth when it comes to the markets.

Case in point, Valeant Pharmaceuticals has cratered since October 2015, but many investors cling to the belief that the company's problems will be solved.

Some hedge funds have (or had until the stock collapsed) as much as 20% to 30% of their capital in the company, which is extraordinarily reckless.

But it's all in the numbers. The masses are missing these figures, but you don't have to...